Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung; Alagie Jassey; Ching Hsuan Liu; Chien Ju Lin; Chun Ching Lin; Shu Hui Wong; Jonathan Y. Wang; Ming Hong Yen; Liang Tzung Lin

doi:10.1016/j.phymed.2022.154128

Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung, Alagie Jassey, Ching Hsuan Liu, Chien Ju Lin, Chun Ching Lin, Shu Hui Wong, Jonathan Y. Wang, Ming Hong Yen, Liang Tzung Lin

Medicine

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

Resumen

In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

Idioma original	English
Número de artículo	154128
Publicación	Phytomedicine
Volumen	102
DOI	https://doi.org/10.1016/j.phymed.2022.154128
Estado	Published - jul. 20 2022

Nota bibliográfica

Publisher Copyright:
© 2022 Elsevier GmbH

ASJC Scopus Subject Areas

Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and alternative medicine

PubMed: MeSH publication types

Published Erratum

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.phymed.2022.154128

Otros archivos y enlaces

Citar esto

Hung, T. C., Jassey, A., Liu, C. H., Lin, C. J., Lin, C. C., Wong, S. H., Wang, J. Y., Yen, M. H., & Lin, L. T. (2022). Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025)). Phytomedicine, 102, Artículo 154128. https://doi.org/10.1016/j.phymed.2022.154128

Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025)). / Hung, Ting Chun; Jassey, Alagie; Liu, Ching Hsuan et al.
En: Phytomedicine, Vol. 102, 154128, 20.07.2022.

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

@article{f49d6583c60048ec92a37e5bf1f5981a,

title = "Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))",

abstract = "In P.67, Section BBR interacts with HCV envelope glycoprotein E2: {"}E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol{"} should read {"}E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol{"}; and {"}the highest binding energy of 6.7 kcal/mol{"} should read {"}the lowest binding energy of −6.7 kcal/mol{"}.",

author = "Hung, {Ting Chun} and Alagie Jassey and Liu, {Ching Hsuan} and Lin, {Chien Ju} and Lin, {Chun Ching} and Wong, {Shu Hui} and Wang, {Jonathan Y.} and Yen, {Ming Hong} and Lin, {Liang Tzung}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier GmbH",

year = "2022",

month = jul,

day = "20",

doi = "10.1016/j.phymed.2022.154128",

language = "English",

volume = "102",

journal = "Phytomedicine",

issn = "0944-7113",

publisher = "Urban und Fischer Verlag Jena",

}

TY - JOUR

T1 - Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

AU - Hung, Ting Chun

AU - Jassey, Alagie

AU - Liu, Ching Hsuan

AU - Lin, Chien Ju

AU - Lin, Chun Ching

AU - Wong, Shu Hui

AU - Wang, Jonathan Y.

AU - Yen, Ming Hong

AU - Lin, Liang Tzung

PY - 2022/7/20

Y1 - 2022/7/20

N2 - In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

AB - In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

UR - http://www.scopus.com/inward/record.url?scp=85129742214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129742214&partnerID=8YFLogxK

U2 - 10.1016/j.phymed.2022.154128

DO - 10.1016/j.phymed.2022.154128

M3 - Comment/debate

C2 - 35550221

AN - SCOPUS:85129742214

SN - 0944-7113

VL - 102

JO - Phytomedicine

JF - Phytomedicine

M1 - 154128

ER -

Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto